What Is Hindsight Bias In Investing?
You’ve probably heard the expression “hindsight is 20/20.” That saying…
Sell
5
OLMA Quote, Financials, Valuation and Earnings
Last price:
$4.21
Seasonality move
:
11.81%
Day range:
$4.19 - $4.45
52-week range:
$3.94 - $16.62
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.70x
Volume:
531.1K
Avg. volume:
916.5K
1-year change:
-61.8%
Market cap:
$286.3M
Revenue:
--
EPS (TTM):
-$2.10
Earnings Data
Next earnings date for OLMA
May 08
2025
Most recent earnings per share
-$0.40
Missed by $0.57
(Mar 18/2025)
Consensus Estimate
$0.17
(Mar 18/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
OLMA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/08/2025 | Q1 | -- | -- | -- | -$0.50 | -- |
| 03/18/2025 | Q4 | -- | -- | -$0.40 | $0.17 | -$0.57 |
| 11/12/2024 | Q3 | -- | -- | -$0.60 | -$0.57 | -$0.03 |
| 08/06/2024 | Q2 | -- | -- | -$0.54 | -$0.54 | $0.00 |
| 05/08/2024 | Q1 | -- | -- | -$0.56 | -$0.55 | -$0.01 |
| 03/11/2024 | Q4 | -- | -- | -$0.48 | -$0.46 | -$0.02 |
| 11/07/2023 | Q3 | -- | -- | -$0.48 | -$0.51 | $0.03 |
| 08/08/2023 | Q2 | -- | -- | -$0.49 | -$0.71 | $0.22 |
| 05/09/2023 | Q1 | -- | -- | -$0.70 | -$0.69 | -$0.01 |
| 03/09/2023 | Q4 | -- | -- | -$0.65 | -$0.62 | -$0.03 |
| 11/08/2022 | Q3 | -- | -- | -$0.57 | -$0.78 | $0.21 |
| 08/09/2022 | Q2 | -- | -- | -$0.82 | -$0.66 | -$0.16 |
| 05/09/2022 | Q1 | -- | -- | -$0.58 | -$0.60 | $0.02 |
| 02/28/2022 | Q4 | -- | -- | -$0.54 | -$0.46 | -$0.08 |
| 11/10/2021 | Q3 | -- | -- | -$0.45 | -$0.43 | -$0.02 |
| 08/10/2021 | Q2 | -- | -- | -$0.42 | -$0.38 | -$0.04 |
| 05/11/2021 | Q1 | -- | -- | -$0.39 | -$0.27 | -$0.12 |
| 03/17/2021 | Q4 | -- | -- | -$0.50 | -$0.16 | -$0.35 |
| 09/30/2020 | Q3 | -- | -- | -$0.26 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.12 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.07 | -- | -- |
Olema Pharmaceuticals Earnings Questions
-
How Much did Olema Pharmaceuticals Generate in Revenue Last Quarter?
Olema Pharmaceuticals reported -- worth of top line sales in its most recent quarter.
-
Did Olema Pharmaceuticals Beat Earnings Last Quarter?
Olema Pharmaceuticals announced earnings per share of -$0.40 which represents a miss of analyst forecast a $0.17 per share.
-
Is Olema Pharmaceuticals Profitable?
Olema Pharmaceuticals reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Olema Pharmaceuticals EPS Next Year?
Olema Pharmaceuticals's earnings are forecast to decrease from -$2.20 per share to -$1.36 per share next year representing a decrease of -2.85%.
-
When is Olema Pharmaceuticals's Earnings Date?
Olema Pharmaceuticals's next earnings date is May 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Rivian a Good Stock a Buy?
Rivian Automotive (RIVN) had an initial IPO of close to…
Will Chevron Acquire Hess?
Long-time Buffett favorite in the energy sector Chevron (NYSE:CVX) is…
Stock Ideas
Buy
58
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
47
RGC alert for Mar 26
Regencell Bioscience Holdings [RGC] is up 4.9% over the past day.
Sell
39
W alert for Mar 26
Wayfair [W] is up 2.01% over the past day.
Sell
46
TSLA alert for Mar 26
Tesla [TSLA] is up 3.5% over the past day.
